Afatinib plus cetuximab delays resistance compared to...

  • Main
  • 2015 / 09
  • Afatinib plus cetuximab delays resistance compared to...

Afatinib plus cetuximab delays resistance compared to single agent erlotinib or afatinib in mouse models of TKI-naive EGFR L858R-induced lung adenocarcinoma

Pirazzoli, V., Ayeni, D., Meador, C. B., Sanganahalli, B., Hyder, F., de Stanchina, E., Goldberg, S. B., Pao, W., Politi, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-0620
Date:
September, 2015
File:
PDF, 1.12 MB
english, 2015
Conversion to is in progress
Conversion to is failed